Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
AgeX Therapeutics, Inc. (AGE)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/06/2023 |
8-K
| Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial ... |
| 08/25/2023 |
8-K
| Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial ... |
| 08/14/2023 |
8-K
| Quarterly results |
| 08/04/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...|
Docs:
|
"AMENDED AND RESTATED CONVERTIBLE PROMISSORY NOTE This Fourth Amendment to Amended and Restated Convertible Promissory Note by and between AgeX Therapeutics Inc., a Delaware corporation and a company incorporated in the Isle of Man with company number 018008V and its registered office at 1st Floor Viking House, St Pauls Square, Ramsey, Isle of Man, IM8 1GB is effective as of July 21, 2023 . WHEREAS, Borrower and Lender entered into the Amended and Restated Convertible Promissory Note, dated February 9, 2023 ; WHEREAS, Borrower and Lender wish to further amend the Note. NOW, THEREFORE, in consideration of the premises set forth above and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Borrower and Lender agree as follows: 1. Definition...",
"SECURED CONVERTIBLE PROMISSORY NOTE This Amendment to Secured Convertible Promissory Note by and between AgeX Therapeutics Inc., a Delaware corporation and a company incorporated in the Isle of Man with company number 018008V and its registered office at 1st Floor Viking House, St Pauls Square, Ramsey, Isle of Man, IM8 1GB is effective as of July 21, 2023 . WHEREAS, Borrower and Lender entered into the Secured Convertible Promissory Note, dated March 13, 2023 ; WHEREAS, Borrower and Lender wish to further amend the Note. NOW, THEREFORE, in consideration of the premises set forth above and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Borrower and Lender agree as follows: 1. Definitions . Capitalized terms used and not defined in th..." |
|
| 07/21/2023 |
8-K
| Quarterly results |
| 07/07/2023 |
8-K
| Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial ... |
| 06/08/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 05/23/2023 |
8-K
| Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Notice of ... |
| 05/12/2023 |
8-K
| Quarterly results |
| 04/26/2023 |
8-K
| Quarterly results |
| 04/06/2023 |
8-K
| Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregister... |
| 03/31/2023 |
8-K
| Quarterly results |
| 03/15/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...|
Docs:
|
"THIS SECURED CONVERTIBLE PROMISSORY NOTE is issued on March 13, 2023 , BY",
"AMENDED AND RESTATED SECURITY AGREEMENT",
"RECITALS",
"Definitions",
"Agreement",
"SECURED CONVERTIBLE FACILITY AGREEMENT This Third Amendment to Secured Convertible Facility Agreement by and between AgeX Therapeutics Inc., a Delaware corporation and Juvenescence Limited, a company incorporated in the Isle of Man with company number 018008V and its registered office at 1st Floor Viking House, St Pauls Square, Ramsey, Isle of Man, IM8 1GB is effective as of March 10, 2023 . WHEREAS, Borrower and Lender, entered into a Secured Convertible Facility Agreement, dated March 30, 2020, as amended by the First Amendment to the Secured Convertible Facility Agreement, dated July 21, 2020 and the Second Amendment to the Secured Convertible Facility Agreement, dated November 12, 2020 ; WHEREAS, the Borrower and Lender wish to amend the Loan Agreement in order to extend the Repayment ..." |
|
| 02/10/2023 |
8-K
| Quarterly results |
| 01/27/2023 |
8-K
| Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregister... |
| 12/16/2022 |
8-K
| Quarterly results |
| 12/12/2022 |
8-K
| Quarterly results |
| 11/25/2022 |
8-K
| Quarterly results |
| 11/10/2022 |
8-K
| Quarterly results |
| 10/21/2022 |
8-K
| Quarterly results |
| 08/19/2022 |
8-K
| Quarterly results |
| 08/12/2022 |
8-K
| Quarterly results |
| 06/10/2022 |
8-K
| Quarterly results |
| 05/18/2022 |
8-K
| Quarterly results |
| 05/13/2022 |
8-K
| Quarterly results |
| 04/06/2022 |
8-K
| Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregister... |
| 03/29/2022 |
8-K
| Quarterly results |
| 03/03/2022 |
8-K
| Quarterly results |
| 02/15/2022 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...|
Docs:
|
"THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED , OR UNDER APPLICABLE STATE SECURITIES LAWS. THIS WARRANT MAY NOT BE EXERCISED, SOLD, PLEDGED, HYPOTHECATED, TRANSFERRED OR ASSIGNED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS, OR PURSUANT TO AN AVAILABLE EXEMPTION FROM REGISTRATION. HEDGING TRANSACTIONS INVOLVING THIS WARRANT OR ANY COMMON STOCK OR OTHER SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE SECURITIES ACT. VOID AFTER 5:00 P.M. NEW YORK TIME ON THE EXPIRATION DATE",
"THIS SECURED CONVERTIBLE PROMISSORY NOTE is issued on February 14, 2022 BY",
"SECURITY AGREEMENT",
"Warrant Agreement Dated as of February 14, 2022",
"Cover Page Interactive Data File (embedded within the Inline XBRL document)" |
|
| 02/04/2022 |
8-K
| Quarterly results |
| 12/30/2021 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 12/09/2021 |
8-K
| Quarterly results |
| 11/23/2021 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and... |
| 11/12/2021 |
8-K
| Quarterly results|
Docs:
|
"AGEX THERAPEUTICS, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS September 30, 2021 December 31, 2020 ASSETS CURRENT ASSETS Cash and cash equivalents $ 731 $ 527 Accounts and grants receivable, net 24 326 Prepaid expenses and other current assets 720 1,430 Total current assets 1,475 2,283 Deposits and other long-term assets 50 50 Intangible assets, net 902 1,592 TOTAL ASSETS $ 2,427 $ 3,925 LIABILITIES AND STOCKHOLDERS’ DEFICIT CURRENT LIABILITIES Accounts payable and accrued liabilities $ 924 $ 1,656 Loan due to Juvenescence, net of debt issuance cost, current portion 5,600 1,960 Related party payables, net 71 71 Deferred revenues, current portion - 275 Paycheck Protection Program Loan - 436 Insurance premium liability and other current liabilities 3 959 Total current liabil..." |
|
|
|
|